TrialJournal of translational medicine2021

Blood-based extracellular matrix biomarkers as predictors of survival in patients with metastatic pancreatic ductal adenocarcinoma receiving pegvorhyaluronidase alfa.

Song Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.